Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Eteplirsen for Patients with Duchenne Muscular Dystrophy with Deletion Mutations Amenable to Exon 51 Skipping

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Greece Hungary +7
  • Study on the Safety and Effectiveness of Peginterferon Beta-1a for Children and Teens with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Bulgaria Croatia Czechia Hungary Slovakia
  • Study on the Safety and Effectiveness of Nerve Growth Factor CHF6467 for Children and Young Adults with Optic Pathway Glioma

    Not recruiting

    1 1
    Italy
  • Study on the Effectiveness and Safety of Chloroprocaine Hydrochloride for Children Undergoing Flat Foot or Inguinal Hernia Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study of Setmelanotide for Patients with Obesity Due to Specific Genetic Variants

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece The Netherlands Spain
  • Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Safety Study of 5-Aminolevulinic Acid for Brain Tumor Surgery in Children and Adolescents

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany The Netherlands
  • Study on Bevacizumab Injections for Patients with Coats’ Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of tenofovir disoproxil versus placebo for children aged 2-12 years with chronic hepatitis B infection

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Romania
  • Study on the Effectiveness and Safety of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Germany Italy The Netherlands